Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, january 2012 to june 2013

Eurosurveillance

Volumn 20, Issue 35, 2015, Pages

  Coppola, N ^a   Alessio, L ^a,b   Gualdieri, L ^c   Pisaturo, M ^d,e   Sagnelli, C ^a,b   Caprio, N ^a,f   Maffei, R ^a,c   Starace, M ^a   Angelillo, I F ^a   Pasquale, G ^a   Sagnelli, E ^a,e  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Medical Center   (Italy)

^c Medical Center   (Italy)

^d Medical Center   (Italy)

^e Endocrinologia e Malattie del Ricambio   (Italy)

^f Medical center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HEPATITIS B ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; ITALY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; REFUGEE; SCREENING; SERODIAGNOSIS; UNSAFE SEX; WESTERN BLOTTING; AFRICA; BLOOD; EASTERN EUROPE; EPIDEMIOLOGY; ETHNOLOGY; GENETICS; GENOTYPE; HEALTH SURVEY; HEPACIVIRUS; HIV INFECTIONS; INDIA; ISOLATION AND PURIFICATION; MIGRANT; PAKISTAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; AFRICA, NORTHERN; DNA, VIRAL; EMIGRANTS AND IMMIGRANTS; EUROPE, EASTERN; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; INDIA; ITALY; MALE; PAKISTAN; POPULATION SURVEILLANCE; REFUGEES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84941253595     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.35.30009     Document Type: Article

References (39)

1. Williams R. Global challenges in liver disease. Hepatology. 2006;44(3):521-6. DOI: 10.1002/hep.21347 PMID: 16941687
2. World Health Organization (WHO). Countries. Geneva: WHO. [Accessed 22 Aug 2015]. Available from: http://www.who.int/ countries/en/
3. Schweitzer A, Horn J, Mikolajczyk R T, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015. pii: S0140-6736(15)61412-X. doi: 10.1016/S0140-6736(15)61412-X. [Epub ahead of print].
4. Stasi C, Silvestri C, Voller F, Cipriani F. The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine. J Infect Public Health. 2015. pii: S1876-0341(15)00101-X. doi:DOI: 10.1016/j. jiph.2015.05.004 [Epub ahead of print].
5. van Sighem A, Nakagawa F, De Angelis D, Quinten C, Bezemer D, de Coul EO, et al. Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data. Epidemiology. 2015;26(5):653-60. DOI: 10.1097/ EDE.0000000000000324 PMID: 26214334
6. Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention.Lancet. 2014;384(9939):258-71. DOI: 10.1016/S0140-6736(14)60164-1 PMID: 24907868
7. Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, Ferrigno L, et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J Med Virol. 2005;75(4):522-7. DOI: 10.1002/jmv.20313 PMID: 15714480
8. Italian Hospitals’ Collaborating Group,Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio PL. Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection.Clin Infect Dis. 2008;46(1):110-3. DOI: 10.1086/524074 PMID: 18171224
9. Centro Operativo AIDS [(AIDS Operative Center] (COA). Notiziario dell’istituto Superiore di Sanità. Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 decembre 2013. [News of the National Institute of Health on the new diagnosis of HIV infection and AIDS in Italy at 31 December 2013]. 2014;27(9 Suppl 1);1-47. Italian. Available from: http://www.iss.it/binary/ccoa/cont/ONLINE_6_ COA_2014.pdf
10. McCarthy AE, Weld LH, Barnett ED, So H, Coyle C, Greenaway C, et al. Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 2: migrants resettled internationally and evaluated for specific health concerns. Clin Infect Dis. 2013;56(7):925-33. DOI: 10.1093/cid/cis1016 PMID: 23223602
11. Caritas and Migrantes. XXIV Rapporto Immigrazione 2014. [XXIV report on immigration 2014]. Rome: Caritas and Migrantes; June 2015. p.1-25. Italian. [Accessed 22 Aug 2015]. Available from: http://www.caritasitaliana.it/materiali//Pubblicazioni/libri_2015/Rapporto_Immigrazione/sintesi_rapportoimmigrazione2014_quadroregionale.pdf
12. Walker PF, Jaranson J. Refugee and immigrant health care.Med Clin North Am. 1999;83(4):1103-20, viii.PMID: 10453265
13. Determinazione 20 marzo 2008. Linee guida per la classificazione e conduzione degli studi osservazionali sui farmaci. (GU Serie Generale n.76 del 31-3-2008). [Definition 20 March 2008.Guideline for the classification and managing of observational studies on drugs]. Gazzetta ufficiale della Repubblica Italiana. [Official Gazette of the Italian Republic]. 31 Mar 2008. Number 76. [Accessed 22 Aug 2015]. Italy. Available from: http://www.gazzettaufficiale.it/eli/ id/2008/03/31/08A02109/sg
14. Sagnelli C, Ciccozzi M, Pisaturo M, Lo Presti A, Cella E, Coppola N, et al. The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. New Microbiol. 2015;38(2):137-47.PMID: 25915056
15. Sagnelli E, Pisaturo M, Stanzione M, Messina V, Alessio L, Sagnelli C, et al. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C. Clin Gastroenterol Hepatol. 2013;11(9):1174-1180. e11. DOI: 10.1016/j.cgh.2013.03.025 PMID: 23591280
16. Sagnelli E, Imparato M, Coppola N, Pisapia R, Sagnelli C, Messina V, et al. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. J Med Virol. 2008;80(9):1547-53. DOI: 10.1002/jmv.21239 PMID: 18649338
17. Coppola N, Pisapia R, Tonziello G, Masiello A, Martini S, Pisaturo M, et al. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCVIgM titre and IgG Avidity Index. J Clin Virol. 2009;46(3):222-9. DOI: 10.1016/j.jcv.2009.08.009 PMID: 19758839
18. Sagnelli C, Ciccozzi M, Pisaturo M, Zehender G, Lo Presti A, Alessio L, et al. Molecular epidemiology of hepatitis B virus genotypes circulating in acute hepatitis B patients in the Campania region. J Med Virol. 2014;86(10):1683-93. DOI: 10.1002/jmv.24005 PMID: 24980631
19. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of agespecific HBsAg seroprevalence and endemicity.Vaccine. 2012;30(12):2212-9. DOI: 10.1016/j.vaccine.2011.12.116 PMID: 22273662
20. Chevaliez S. Virological tools to diagnose and monitor hepatitis C virus infection.Clin Microbiol Infect. 2011;17(2):116-21. DOI: 10.1111/j.1469-0691.2010.03418.x PMID: 21054664
21. Sagnelli E, Sagnelli C, Pisaturo M, Coppola N. Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection. Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection. World J Gastroenterol. 2014;20(22):6707-15. DOI: 10.3748/wjg.v20.i22.6707 PMID: 24944463
22. Stornaiuolo G, Cuniato V, Cuomo G, Nocera E, Brancaccio G, De Rosa M, et al. Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections. Dig Liver Dis. 2014;46(1):62-6. DOI: 10.1016/j.dld.2013.08.126 PMID: 24148806
23. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1-20.PMID: 18802412
24. Majori S, Baldo V, Tommasi I, Malizia M, Floreani A, Monteiro G, et al. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy). J Travel Med. 2008;15(5):323-7. DOI: 10.1111/j.1708-8305.2008.00230.x PMID: 19006505
25. Tafuri S, Prato R, Martinelli D, Melpignano L, De Palma M, Quarto M, et al. Prevalence of Hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy. BMC Infect Dis. 2010;10:213. doi: 10.1186/1471-2334-10-213
26. Chironna M, Germinario C, Lopalco PL, Quarto M, Barbuti S. H BV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region).Epidemiol Infect. 2000;125(1):163-7. DOI: 10.1017/S0950268899004215 PMID: 11057972
27. Chironna M, Germinario C, Lopalco PL, Carrozzini F, QuartoM. Prevalence of hepatitis virus infections in Kosovar refugees. Int J Infect Dis. 2001;5(4):209-13. DOI: 10.1016/S1201-9712(01)90073-6 PMID: 11953219
28. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Barbuti S, Quarto M. Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey.Infection. 2003;31(2):70-4. DOI: 10.1007/s15010-002-3100-3 PMID: 12682810
29. Palumbo E, Scotto G, Faleo G, Cibelli DC, Saracino A, Angarano G. Prevalence of HBV-genotypes in immigrants affected by HBV-related chronic active hepatitis.Arq Gastroenterol. 2007;44(1):54-7. DOI: 10.1590/S0004-28032007000100012 PMID: 17639184
30. Sagnelli E, Sagnelli C, Pisaturo M, Macera M, Coppola N. Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy.World J Gastroenterol. 2014;20(24):7635-43. DOI: 10.3748/wjg.v20.i24.7635 PMID: 24976701
31. World Health Organization (WHO). Global Health Observatory (GHO) data. HIV/AIDS prevalence in sub-Saharan Africa. Geneva: WHO. [Accessed 22 Aug 2015]. Available from: http://www.who.int/gho/urban_health/outcomes/hiv_prevalence:text/en/
32. Zanetti AR, Tanzi E, Romanò L, GrappasonniI. Vaccination against hepatitis B: the Italian strategy.Vaccine. 1993;11(5):521-4. DOI: 10.1016/0264-410X(93)90222-J PMID: 8488702
33. Federal Ministry of Health, Department of Public Health, National AIDS/STDs Control Programme. Technical report. 2010 national HIV sero-prevalence sentinel survey. Abuja: Federal Ministry of Health. [Accessed 1 Sep 2015]. Available from: http://www.nigeria-aids.org/documents/2010_National%20HIV%20Sero%20Prevalence%20Sentinel%20Survey.pdf
34. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ. 2010;88(11):847-53. doi: 10.2471/ BLT.10.076349.
35. Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine. 2003;21(7-8):685-91. DOI: 10.1016/S0264-410X(02)00580-7 PMID: 12531340
36. Da Villa G, Sepe A. Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness.Vaccine. 1999;17(13-14):1734-8. DOI: 10.1016/S0264-410X(98)00414-9 PMID: 10194831
37. Hennessey K, Mendoza-Aldana J, Bayutas B, Lorenzo-Mariano KM, DiorditsaS. Hepatitis B control in the World Health Organization’s Western Pacific Region: targets, strategies, status.Vaccine. 2013;31(Suppl 9):J85-92. DOI: 10.1016/jvaccine.2012.10.082 PMID: 24331026
38. Hladun O, Grau A, Esteban E, Jansà JM. Results from screening immigrants of low-income countries: data from a public primary health care.J Travel Med. 2014;21(2):92-8. DOI: 10.1111/ jtm.12083 PMID: 24571720
39. Papadakis G, Okoba NA, Nicolaou C, Boufidou F, Ioannidis A, Bersimis S, et al. Serologic markers for H BV, HCV and HIV in immigrants visiting the Athens’ polyclinic of ‘Doctors of the World-Greece’. Public Health. 2013;127(11):1045-7. DOI: 10.1016/j.puhe.2013.08.001 PMID: 24238081